Literature DB >> 12431861

Sleep and sleep homeostasis in mice lacking the 5-HT2c receptor.

Marcos G Frank1, Michael P Stryker, Laurence H Tecott.   

Abstract

Studies in humans and rats indicate that serotonin (5-hydroxytryptamine, 5-HT) receptors are involved in mammalian sleep expression. We investigated the contribution of the 5-HT2c receptor to sleep expression by examining sleep patterns in mice bearing a targeted null mutation of this receptor. 5-HT2c receptor knock-out mice had more wakefulness, several abnormalities in rapid eye movement sleep expression and an enhanced response to sleep deprivation compared with wild-type control mice. These findings suggest that 5HT2c receptors may mediate several effects on sleep that have been ascribed to serotonin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431861      PMCID: PMC2452994          DOI: 10.1016/S0893-133X(02)00353-6

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  15 in total

1.  An automated system for recording and analysis of sleep in mice.

Authors:  S C Veasey; O Valladares; P Fenik; D Kapfhamer; L Sanford; J Benington; M Bucan
Journal:  Sleep       Date:  2000-12-15       Impact factor: 5.849

2.  The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors.

Authors:  D Julius; K N Huang; T J Livelli; R Axel; T M Jessell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Recovery sleep and performance following sleep deprivation with dextroamphetamine.

Authors:  J L Caldwell; J A Caldwell
Journal:  J Sleep Res       Date:  1997-06       Impact factor: 3.981

4.  Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain.

Authors:  D E Wright; K B Seroogy; K H Lundgren; B M Davis; L Jennes
Journal:  J Comp Neurol       Date:  1995-01-16       Impact factor: 3.215

5.  Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat.

Authors:  A Gobert; J M Rivet; F Lejeune; A Newman-Tancredi; A Adhumeau-Auclair; J P Nicolas; L Cistarelli; C Melon; M J Millan
Journal:  Synapse       Date:  2000-06-01       Impact factor: 2.562

6.  SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.

Authors:  V Di Matteo; G Di Giovanni; M Di Mascio; E Esposito
Journal:  Neuropharmacology       Date:  1999-08       Impact factor: 5.250

7.  Monoaminergic and cholinergic modulation of REM-sleep timing in rats.

Authors:  J H Benington; H C Heller
Journal:  Brain Res       Date:  1995-05-29       Impact factor: 3.252

8.  Neonatal treatments with the serotonin uptake inhibitors clomipramine and zimelidine, but not the noradrenaline uptake inhibitor desipramine, disrupt sleep patterns in adult rats.

Authors:  M G Frank; H C Heller
Journal:  Brain Res       Date:  1997-09-12       Impact factor: 3.252

9.  Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat.

Authors:  M Touret; M Sallanon-Moulin; M Jouvet
Journal:  Neurosci Lett       Date:  1995-04-07       Impact factor: 3.046

10.  Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.

Authors:  A L Sharpley; J M Elliott; M J Attenburrow; P J Cowen
Journal:  Neuropharmacology       Date:  1994 Mar-Apr       Impact factor: 5.250

View more
  26 in total

Review 1.  Genetic analysis of sleep.

Authors:  Amanda Crocker; Amita Sehgal
Journal:  Genes Dev       Date:  2010-06-15       Impact factor: 11.361

2.  Endogenous nonneuronal modulators of synaptic transmission control cortical slow oscillations in vivo.

Authors:  Tommaso Fellin; Michael M Halassa; Miho Terunuma; Francesca Succol; Hajime Takano; Marcos Frank; Stephen J Moss; Philip G Haydon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

3.  Effects of a Serotonin 2C Agonist and a 2A Antagonist on Actigraphy-Based Sleep Parameters Disrupted by Methamphetamine Self-Administration in Rhesus Monkeys.

Authors:  Maylen Perez Diaz; Monica L Andersen; Kenner C Rice; Leonard L Howell
Journal:  Neuropsychopharmacology       Date:  2016-12-16       Impact factor: 7.853

4.  The Genetics of Sleep: Insight from Rodent Models.

Authors:  Keith C Summa; Fred W Turek
Journal:  Sleep Med Clin       Date:  2011-06-01

Review 5.  Mammalian sleep genetics.

Authors:  Jessica M Kelly; Matt T Bianchi
Journal:  Neurogenetics       Date:  2012-09-14       Impact factor: 2.660

6.  Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity.

Authors:  Diána Kostyalik; Zita Kátai; Szilvia Vas; Dorottya Pap; Péter Petschner; Eszter Molnár; István Gyertyán; Lajos Kalmár; László Tóthfalusi; Gyorgy Bagdy
Journal:  Exp Brain Res       Date:  2014-01-07       Impact factor: 1.972

7.  Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss.

Authors:  Michael M Halassa; Cedrick Florian; Tommaso Fellin; James R Munoz; So-Young Lee; Ted Abel; Philip G Haydon; Marcos G Frank
Journal:  Neuron       Date:  2009-01-29       Impact factor: 17.173

8.  Selective 5HT2A and 5HT6 receptor antagonists promote sleep in rats.

Authors:  Stephen R Morairty; Linda Hedley; Judith Flores; Renee Martin; Thomas S Kilduff
Journal:  Sleep       Date:  2008-01       Impact factor: 5.849

9.  A Role for Astroglial Calcium in Mammalian Sleep and Sleep Regulation.

Authors:  Ashley M Ingiosi; Christopher R Hayworth; Daniel O Harvey; Kristan G Singletary; Michael J Rempe; Jonathan P Wisor; Marcos G Frank
Journal:  Curr Biol       Date:  2020-09-24       Impact factor: 10.834

10.  Gasping activity in vitro: a rhythm dependent on 5-HT2A receptors.

Authors:  Andrew K Tryba; Fernando Peña; Jan-Marino Ramirez
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.